GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags
Key Terms
ct (computed tomography)medical
A CT (computed tomography) scan is a medical imaging technique that uses X‑rays and a computer to create detailed cross‑sectional pictures of the body, like slicing a loaf of bread to see each layer. Investors care because CT machines and associated software drive hospital and clinic spending, influence revenue for medical device makers and diagnostic centers, and are affected by regulation, reimbursement and technological advances that can change market demand and profitability.
non-communicable diseasesmedical
Non-communicable diseases are long-term medical conditions that are not spread from person to person, such as heart disease, cancer, diabetes and chronic lung conditions; they often develop from a mix of genetics, lifestyle and environmental factors. For investors they matter because they drive predictable, growing demand for drugs, diagnostics, medical devices, insurance and chronic care services—like a slow-moving tide that shapes long-term healthcare spending, markets and regulatory priorities.
pandemic resiliencemedical
Pandemic resilience describes a company’s ability to withstand, adapt to, and recover from widespread infectious-disease outbreaks and the disruptions they cause to employees, supply chains, demand, and operations. Investors care because resilient firms behave like buildings built to survive storms: they suffer smaller losses, restore revenue faster, and reduce the chance of sudden cash-flow problems, making them less risky and more likely to protect shareholder value during future public-health crises.
biopsiesmedical
A biopsy is a medical procedure that removes a small piece of tissue or cells so doctors can examine it under a microscope to diagnose disease or measure how well a treatment is working. For investors, biopsy results can change the outlook for drug development, regulatory approval, and diagnostic markets—think of it like taking a spoonful from a pot to check the recipe before deciding whether to back the chef or the product.
radiotherapymedical
Radiotherapy is a medical treatment that uses targeted high-energy radiation to shrink or destroy tumors and control disease, similar to using a focused beam to remove weeds without digging up the whole garden. It matters to investors because approvals, new technologies, clinical trial results, or changes in treatment guidelines can affect demand for equipment, drug combinations, and patient outcomes, which in turn influence revenue and growth prospects for healthcare companies.
supply chain resiliencetechnical
Supply chain resilience is the ability of a system to quickly adapt and recover from disruptions that could interrupt the flow of goods, services, or resources. It is like having a backup plan or extra flexibility to keep things running smoothly despite unexpected problems. For investors, strong supply chain resilience can indicate a company's or economy's capacity to maintain stability and continue growth even during challenging times.
imaging technologiesmedical
Imaging technologies are tools and machines that produce pictures of the inside of a body or object—for example X-ray, MRI, CT, ultrasound, PET and advanced optical or molecular scanners—allowing doctors and researchers to see structure and function without surgery. They matter to investors because new devices, software or regulatory approvals can change how many patients get diagnosed and treated, affecting sales, clinical progress and the value of medical-equipment and diagnostics companies; think of them as the camera and map that guide clinical decisions and market demand.
ct technologymedical
CT technology is medical imaging equipment that uses X‑rays and computer processing to create detailed cross‑sectional pictures of the body's internal structures, like a high‑resolution camera that can look inside a loaf of bread without cutting it. Investors watch developments in CT technology because improvements, regulatory approvals, and wider hospital adoption can drive sales, recurring service and software revenue, and influence reimbursement and competitive positioning in the healthcare market.
300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.
Collaboration supports Indonesian Government’s agenda to enhance diagnostic access and build national healthcare resilience.
Multi-year agreement builds on GE HealthCare’s continued investment in local manufacturing, capability building and knowledge transfer to strengthen Indonesia’s healthcare ecosystem.
JAKARTA, Indonesia--(BUSINESS WIRE)--
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations.
SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience.
By modernizing the referral network and expanding access to advanced diagnostics across all provinces, the collaboration is bringing equitable, high-quality care closer to every community—urban and remote alike. Access to life-saving CT technology will enable early detection and timely treatment of critical conditions such as cancer, stroke, and heart disease, helping save lives and improve health outcomes for Indonesians nationwide.
“We are proud to support the Indonesian Ministry of Health’s vision,” said Elie Chaillot, President & CEO, International at GE HealthCare. “Our ongoing investments in local manufacturing, capacity building and training reflect our commitment to contribute to Indonesia’s healthcare resilience and drive local economic growth. Equally important, this initiative helps ensure that advanced diagnostic technologies reach rural and remote communities, promoting healthcare equity and bringing life-saving care closer to every Indonesian.”
CT scanners have become essential in modern healthcare. Using X-ray beams and advanced computer processing, CT scanners provide fast, detailed 2D and 3D images of the internal organs, bones, blood vessels, and soft tissues, helping doctors diagnose injuries and illnesses quickly. CT technology enables early detection of conditions, determines the size and spread of tumors or infections, monitors treatment effectiveness (such as chemotherapy or radiotherapy), and guides procedures like biopsies in deep organs.
To deepen its local footprint, GE HealthCare recently inaugurated a production facility in Bogor, in collaboration with PT Kalbe Farma’s subsidiary, Forsta. This local manufacturing facility is aimed at strengthening Indonesia’s supply chain resilience, supporting technology transfer and helping develop a skilled local healthcare and technical workforce.
For over seven decades, GE HealthCare has collaborated with Indonesia’s public and private healthcare sectors. In early 2025, GE HealthCare was awarded a tender to supply 10 1.5T MR systems to public hospitals. High resolution MR imaging enables early, accurate diagnosis and ongoing monitoring of conditions like cancer, stroke and heart disease, and is critical for effective non-communicable disease management.
In 2024, GE HealthCare established the Regional Innovation & Training Experience (RITE) Hub in Jakarta. The center provides Indonesian healthcare professionals with hands-on training on advanced imaging technologies, including MR and CT systems, and collaborates with leading educational institutions to deliver programs covering device operation and clinical pathways. By equipping clinicians with practical skills and knowledge, the center strengthens local expertise and ensures medical technologies are used to their maximum potential across Indonesia.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.
